Propionylcarnitine

Basic information

Metabolite name	Propionylcarnitine
	HMDB0000824
	C03017
	188824
Synonyms	Propionylcarnitine (C3); carnitine C3:0; Propionyl-L-carnitine
No. of studies	15

Relationship between Propionylcarnitine and depression (count: 15)

Study	Study Type	Comparison groups	Tissue	Organism	Up/Down regulated
Study M007	Type1	CRS group vs. control group	Plasma	Wistar rat	Down
Study M052	Type1	HIV-positive and HIV-negative cohorts depressed vs. controls	Plasma	Human	Down
Study M061	Type1	depressed group vs. control group	Plasma	Human	Down
Study M087	Type2	esketamine group 2-h vs. baseline	Plasma	Human	Down
Study M1007	Type1	CUMS group vs. control group	Serum	Sprague-Dawley rat	Down
Study M1007	Type2	CUMS + bifid triple viable capsules group vs. CUMS group	Serum	Sprague-Dawley rat	Up
Study M1024	Type1	CUMS group vs. control group	Serum	ICR mouse	Up
Study M1024	Type2	CUMS + hydroxytyrosol group vs. CUMS group	Serum	ICR mouse	Down
Study M104	Type1	CUMS group vs. control group	Serum	Sprague-Dawley rat	Down
Study M104	Type2	CUMS + BH group vs. CUMS group	Serum	Sprague-Dawley rat	Up
Study M1072	Type1	CUMS group vs. control group	Amygdala	Cynomolgus monkey	Down
Study M541	Type1	CUMS group vs. control group	Serum	Sprague-Dawley rat	Down
Study M587	Type2	MDD group, after 8-week SSRI treatment vs. before treatment	Plasma	Human	Up
Study M613	Type1	CSDS susceptible group vs. control group	Ventral hippocampus	C57BL/6 J mouse	Down
Study M648	Type1	ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, discovery cohort	Plasma	Human	Down
Study M690	Type2	CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group	Serum	Balb/c mouse	Up
Study M741	Type2	MDD group, post vs. before SSRI treatment	Plasma	Human	Up
Study M741	Type4	remitter group vs. non-remitter group, baseline	Plasma	Human	Up
Study M847	Type1	CUMS group vs. control group	Liver	Sprague-Dawley rat	Up
Study M847	Type2	CUMS + Bupleuri Radix group vs. CUMS group	Liver	Sprague-Dawley rat	Down